university website

M. Aapro (Matti), F. van Wijk (Femke), G. Bolis (G.), P. Chevallier (Patrice), M.E.L. van der Burg (Maria), A. Poveda (Andrés), J. Oliveira, S. Tumolo (S.), V. Scotto di Palumbo (V.), M.J. Piccart (Martine), et al. M. Franchi (M.), F. Zanaboni (F.), A.J. Lacave, R. Fontanelli (R.), G. Favalli, P. Zola, J.P. Guastalla, R. Rosso (Ricardo), C. Marth (C.), M.A. Nooij, M. Presti (M.), C. Scarabelli (C.), T.A.W. Splinter (Ted), E. Ploch (E.), L.V. Beex (Louk), W.W. Ten Bokkel Huinink (Wim), G. Forni (Gianluca), M. Melpignano (M.), P. Blake (P.), P. Kerbrat (Pierre), C. Mendiola (Cesar), A. Cervantes (Andres), A. Goupil (A.), P.G. Harper (P.), C. Madronal (C.), M. Namer, G. Scarfone (G.), J.E.G.M. Stoot (J. E G M), I. Teodorovic, C. Coens (Corneel), I. Vergote (Ignace) and J.B. Vermorken (Jan)

2003-03-01

Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Publication

Publication

Annals of Oncology , Volume 14 - Issue 3 p. 441- 448

Additional Metadata
Keywords Chemotherapy, Cisplatin, Doxorubin, Endometrial carcinoma, Phase III, Randomised clinical trial
Persistent URL doi.org/10.1093/annonc/mdg112, hdl.handle.net/1765/66299
Journal Annals of Oncology
Organisation Department of Gynaecology & Obstetrics
Citation
Aapro, M., van Wijk, F., Bolis, G., Chevallier, P., van der Burg, M., Poveda, A., Oliveira, J., Tumolo, S., Scotto di Palumbo, V., Piccart, M., Franchi, M., Zanaboni, F., Lacave, A. J., Fontanelli, R., Favalli, G., Zola, P., Guastalla, J. P., Rosso, R., Marth, C., … Vermorken, J. (2003). Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Annals of Oncology, 14(3), 441–448.https://doi.org/10.1093/annonc/mdg112


User Publication Person Organisation Collection
Close